A DPD scan is a type of nuclear medicine imaging test which uses radioactive technetium-99m (99mTc) and 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) to diagnose cardiac amyloidosis. The radiopharmaceutical is taken up only in patients with ATTR amyloidosis, making it a useful tool to differentiate from AL amyloidosis.
DPD is a diphosphonate and can be used as an alternative to HDP or MDP in nuclear medicine bone scintigraphy.
Procedure DPD scanning typically uses a gamma camera to obtain SPECT images, with an injection followed by an initial scan after 5 minutes, and a second scan after 3 hours.
Images are often scored using the "Perugini system" whereby: Grade 0 – no cardiac uptake and normal bone uptake Grade 1 – cardiac uptake which is less intense than the bone signal Grade 2 – cardiac uptake with intensity similar or greater than bone signal Grade 3 – cardiac uptake with much attenuated or absent bone signal
Availability DPD is not currently available in the United States.
See also SAP scan
References